Ebola Facts. October 14, 2014
|
|
- Oliver Ryan
- 6 years ago
- Views:
Transcription
1 Ebola Facts October 14, 2014
2 Symptoms of Ebola Initial symptoms are nonspecific - may include fever, chills, myalgias, and malaise. Patients can progress to develop gastrointestinal symptoms: severe watery diarrhea, nausea, vomiting, abdominal pain Other symptoms: chest pain, shortness of breath, headache or confusion, conjunctival injection, hiccups, seizures, and cerebral edema Bleeding not universally present but can manifest later as petechiae, ecchymosis/ bruising, or oozing. Frank hemorrhage less common. Some develop diffuse erythematous maculopapular rash that can desquamate. Most common symptoms reported during current outbreak: fever (87%) fatigue (76%) vomiting (68%) diarrhea (66%) loss of appetite (65%) Patients with fatal disease develop more severe clinical signs early during infection and die between days 6-16 of complications (mean of 7.5 days). In non-fatal cases, patients may have fever for several days and improve, around day 6. The case fatality proportion in West Africa is about 71% Source: Centers for Disease Control and Prevention.
3 Timeline of Infection Diagnosis of Ebola Diagnosing Ebola can be difficult at first since early symptoms, such as fever, are nonspecific to Ebola infection. However, if a person has the early symptoms and has had contact with Ebola they should be isolated and public health professionals notified. Samples from the patient can then be collected and tested to confirm infection. Within a few days after symptoms begin Later in disease course or after recovery Retrospectively in deceased patients Diagnostic tests available Antigen-capture enzyme-linked immunosorbent assay (ELISA) testing IgM ELISA Polymerase chain reaction (PCR) Virus isolation IgM and IgG antibodies Immunohistochemistry testing PCR Virus isolation Source: Centers for Disease Control and Prevention
4 Source:
5 Treatment of Ebola There are no approved treatments available for EVD. Clinical management focus - supportive care of complications: hypovolemia, electrolyte abnormalities, hematologic abnormalities, refractory shock, hypoxia, hemorrhage, septic shock, multi-organ failure, and DIC. Recommended care includes: volume repletion maintenance of blood pressure (with vasopressors if needed) maintenance of oxygenation pain control nutritional support treating secondary bacterial infections and pre-existing comorbidities Among patients from West Africa, large volumes of intravenous fluids have often been required to correct dehydration due to diarrhea and vomiting. Several investigational therapeutics for Ebola virus disease are in development. There are no approved vaccines available for EVD. Several investigational Ebola vaccines are in development, and Phase I trials are underway for some vaccine candidates. Source: Centers for Disease Control and Prevention.
6 Source: /ebola/pdf/ppeposter.pdf
7
8
9 References Baize S. et al. Emergence of Zaire Ebola Virus Disease in Guinea - Prepminary Report. N Engl J Med Apr 16. epub Feldmann H, Geisbert TW. Ebola Haemorrhagic Fever. Lancet Mar 5;377(9768): Fowler RA, Fletcher T, Fischer WA, et al. Caring for Critically Ill Patients with Ebola Virus Disease: Perspectives from West Africa. Am J Respir Crit Care Med Aug 25. Epub Kortepeter MG, Bausch DG, Bray M. Basic Cpnical and Laboratory Features of Filoviral Hemorrhagic Fever. J Infect Dis Nov;204 Suppl 3:S810-6 WHO Ebola Response Team. Ebola Virus Disease in West Africa The First 9 Months of the Epidemic and Forward Projections. N Eng J Med Sept 23. Epub Source:
Ebola, Emergency Medicine, and Global Bioethics
Ebola, Emergency Medicine, and Global Bioethics Sarah M Winston Bush, MD Assistant Professor University of Cincinnati Department of Emergency Medicine A look at the medicine What does Ebola look like High
More informationIntroduction to Lassa fever
Introduction to Lassa fever Managing infectious hazards Store food in containers with lids OpenWHO.org WHO2017 1 Learning objectives Describe signs, symptoms, and transmission of Lassa fever List 4 preventive
More informationPrimary Care Guideline for the Management of People Concerned About/Potentially Exposed to Ebola. Provincial Ebola Response Task Force Nov.
Primary Care Guideline for the Management of People Concerned About/Potentially Exposed to Ebola Provincial Ebola Response Task Force Nov. 6, 2014 Primary Care Guidelines for the Management of People Concerned
More informationFREQUENTLY ASKED QUESTIONS ABOUT EBOLA VIRUS DISEASE
FREQUENTLY ASKED QUESTIONS ABOUT EBOLA VIRUS DISEASE What is EBOLA? Ebola, previously known as Ebola hemorrhagic fever, is a deadly disease caused by infection with one of the Ebola virus strains. One
More informationEbola Virus Disease (EVD) Preparedness Kit. To: All pharmacists From: Dr. Faith Stratton, Chief Medical Officer of Health Date: October 28, 2014
MEMO: Ebola Virus Disease (EVD) Preparedness Kit To: All pharmacists From: Dr. Faith Stratton, Chief Medical Officer of Health Date: October 28, 2014 This update is to provide information to pharmacists
More informationCopyright Emory Healthcare 2014 All Rights Reserved.
This document is provided as a courtesy to those interested in Emory Healthcare and does not constitute medical or any other advice and does not create any physician-patient relationship. Also, Emory Healthcare
More informationOur Job: Prevent dis-ease as well as disease
Our Job: Prevent dis-ease as well as disease 1 Kansas Ebola Virus Preparedness and Response Plan: Revised 15 October 2014 2 Background and Situation Update 3 West Africa (As of 12 October 2014) Total Cases
More information(Public Health) Management of Ebola Disease. Aura Timen, MD, PhD. National Coordination Centre for Communicable Disease Control (LCI) CIb
(Public Health) Management of Ebola Disease Aura Timen, MD, PhD National Coordination Centre for Communicable Disease Control (LCI) CIb Het hoe,wat en wie van de LCI Everybody knows that pestilences have
More informationEbola Virus Disease: The Future Challenge and Promise of Providing Safe Quality Care
Ebola Virus Disease: The Future Challenge and Promise of Providing Safe Quality Care Daniel Bausch, MD, MPH&TM Technical Lead Epidemic Clinical Management Team WHO Geneva 6 th FIDSSA Congress 2015 Drakensberg,
More informationFrequently Asked Questions About Ebola Virus Disease
Frequently Asked Questions About Ebola Virus Disease Note that many of the answers below are accurate at an identified point in time. For the most recent information, please visit www.cdc.gov/vhf/ebola.
More informationClinical Case Management Guidelines of Ebola Virus Disease (EVD)
Clinical Case Management Guidelines of Ebola Virus Disease (EVD) 1. Introduction Ebola Virus Disease (earlier known as Ebola hemorrhagic fever) is a severe, often fatal disease in humans and nonhuman primates
More informationSince then, outbreaks have appeared sporadically in several African countries.
Ebola Virus Disease (also known as Ebola Hemorrhagic fever) is a severe, often fatal disease caused by infection with a species of Ebola virus. The first Ebola virus species was discovered in 1976 in what
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: WHO Ebola Response Team. Ebola virus disease among children
More informationWhat this is for: Guidance keeping workers safe while handling inquiries and responding to patients with suspected Ebola symptoms.
Interim Guidance for Emergency Medical Services (EMS) Systems and 9-1-1 Public Safety Answering Points (PSAPs) for Management of Patients with Known or Suspected Ebola Virus Disease in the United States
More informationName: Ebola Epidemic: Student Worksheet
Ebola Epidemic: Student Worksheet Ebola Virus Disease (EVD), also known as Ebola hemorrhagic fever, is a rare and deadly disease. The 2014 Ebola epidemic is the largest in history, affecting multiple countries
More informationEmergency Medical Service General Order
Date of Issue: October 15, 2014 Effective Date: October 15, 2014 Plan Classification: Field Operations Commissioner of : No. Pages: 1 of 12 Rescinds: All previous directives Purpose: The U.S. Department
More informationEbola Frequently Asked Questions
Oklahoma State Department of Health Acute Disease Service Public Health Fact Sheet Ebola Frequently Asked Questions What is Ebola Virus Disease? Ebola Virus Disease (EVD) is also called Ebola Hemorrhagic
More informationPatient safety in managing Ebola in resource-rich and poor settings
Patient safety in managing Ebola in resource-rich and poor settings Stephen Mepham Consultant in Microbiology and Infectious Diseases Royal Free London NHS Foundation Trust Colin Brown Infectious Diseases
More informationWebCast For Continuing Education
WebCast For Continuing Education 2016 Northern California EMS, Inc. Engineer Bill Bogenreif. 1 Ebola Virus Disease Update 5/4/2016 Eric M. Rudnick, MD, FACEP,FAAEM Northern California EMS, Inc. Engineer
More informationIMI2 Ebola and other filoviral haemorrhagic fevers programme. Webinar for SRG and SC 3 November 2014
IMI2 Ebola and other filoviral haemorrhagic fevers programme Webinar for SRG and SC 3 November 2014 Background Ebola virus diseases (EVD) is a rare and deadly disease Filoviruses such as Ebola spread directly
More informationEfficacy trials of Lassa Therapeutics: endpoints, trial design, site selection
Efficacy trials of Lassa Therapeutics: endpoints, trial design, site selection WHO Workshop Final Report April 25, 2018 INSERM, Paris, France Table of contents TABLE OF CONTENTS 1 1. INTRODUCTION 2 2.
More informationThe following is an overview of diagnostic techniques for Ebola infection in humans.
IBM Deep Dive Topic 1/14/2015 Alex // operonlabs.com Diagnostics and Ebola: The following is an overview of diagnostic techniques for Ebola infection in humans. Current Status: The current status of Ebola
More informationThe Journal of Infectious Diseases SUPPLEMENT ARTICLE
The Journal of Infectious Diseases SUPPLEMENT ARTICLE Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine
More informationNee-Kofi Mould-Millman, MD. Assistant Professor, Dept of Emergency Medicine Senior Investigator, Center for Global Health
Nee-Kofi Mould-Millman, MD Assistant Professor, Dept of Emergency Medicine Senior Investigator, Center for Global Health No conflicts of interest No financial disclosures 1) To understand pathogenesis
More informationEffects of Antibiotic Treatment on the Results of Nested ACCEPTED. Polymerase Chain Reactions for Scrub Typhus
JCM Accepts, published online ahead of print on 0 August 00 J. Clin. Microbiol. doi:0./jcm.00-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
More informationSurveillance strategy during Phase 3 of the Ebola response
EMERGENCY GUIDANCE Surveillance strategy during Phase 3 of the Ebola response 5 November 2015 World Health Organization 2015. All rights reserved. The designations employed and the presentation of the
More informationTraining Bulletin. Emergency Health Services Branch Ministry of Health and Long-Term Care. October 24, Issue Number version 2.
Training Bulletin Ebola Virus Disease October 24, 2014 Issue Number 114 - version 2.1 Emergency Health Services Branch Ministry of Health and Long-Term Care Training Bulletin, Issue Number 114 version
More informationCalifornia Association for Medical Laboratory Technology. Distance Learning Program
California Association for Medical Laboratory Technology Distance Learning Program EBOLA VIRUS DISEASE Worldwide Implications Course # DL-013 The information in this course is from http://www.cdc.gove/vhf/ebola/healthcare-us/index.html
More information1 - General FAQs about the Ebola virus (pages 1-3)
EBOLA FAQs This document contains three sections of FAQs: 1 - General FAQs about the Ebola virus (pages 1-3) 2 - FAQ for staff who may be meeting guests arriving from infected areas who ve been invited
More informationEbola Q & A. # Question Answer Modified
Ebola Q & A # Question Answer Modified 1 Are U.S. hospitals ready to care for patients with Ebola virus disease (EVD)? Yes any U.S. hospital that is following CDC's infection control recommendations(http://www.cdc.gov/vhf/ebola/hcp/infectionprevention-and-control-recommendations.html)
More informationEbola Virus Disease. West Africa Dr Sylvie Briand. Pandemic and Epidemic Diseases department
Ebola Virus Disease West Africa - 2014 Dr Sylvie Briand 1 Haemorrhagic fever Incubation period: 2 21 days Symptoms: start with fever, intense weakness, muscle pain, headache and sore throat. Followed by
More informationEbola Virus Disease Update. MSDH Office of Epidemiology October 15, 2014
Ebola Virus Disease Update MSDH Office of Epidemiology October 15, 2014 1 EBOLA VIRUS A hemorrhagic fever virus native to Africa with bats serving as the likely reservoir. Transmission events to humans
More informationViral Haemorrhagic Fevers. Major Dan Burns Infectious Diseases Registrar
Viral Haemorrhagic Fevers Major Dan Burns Infectious Diseases Registrar 2 nd June 2018 Outline Viral Haemorrhagic Fevers West Africa Ebola Outbreak Kahoot.com Hit play Enter PIN 2966193 Viral Haemorrhagic
More informationInfectious Disease/EBOLA Guidelines for the School Clinic
Infectious Disease/EBOLA Guidelines for the School Clinic Background: The procedures in the accompanying algorithm provide guidance on evaluation and management of individuals who present with possible
More informationQuantum of Ebola Virus Disease Occurrence and Quantum of Research Publications: A Scientrometric Analysis
Indian Journal of Science and Technology, Vol 8(14), DOI: 10.17485/ijst/2015/v8i14/70707, July 2015 ISSN (Print) : 0974-6846 ISSN (Online) : 0974-5645 Quantum of Ebola Virus Disease Occurrence and Quantum
More informationUsing Complete Blood Cell Counts to Diagnose Disease
Physiology 2 Redwood High School Name Class Period Using Complete Blood Cell Counts to Diagnose Disease Background A healthy adult has about 4.5 to 5 million red blood cells and approximately 8,000 white
More informationEBOLA AND OTHER AFRICAN VIRAL HAEMORRHAGIC FEVERS
EBOLA AND OTHER AFRICAN VIRAL HAEMORRHAGIC FEVERS In response to the 2014 West African Ebola epidemic, last year s G-FINDER survey tracked funding for Ebola R&D for the first time, capturing FY2014 investments.
More informationEBOLA VIRUS DISEASE FLIP BOOK TRAINING GOWHO GO PRE-DEPLOYMENT TRAINING
EBOLA VIRUS DISEASE FLIP BOOK TRAINING GOWHO GO PRE-DEPLOYMENT TRAINING WHO Library Cataloguing-in-Publication Data: Go training: package for Ebola pre-deployment. Contents: Participant handbook Ebola
More informationSelection and use of Ebola in vitro diagnostic (IVD) assays
EMERGENCY GUIDANCE Selection and use of Ebola in vitro diagnostic (IVD) assays June 2015 World Health Organization 2015. All rights reserved. The designations employed and the presentation of the material
More informationDISASTER A total of 2,615 Ebola infections and 1,427 deaths highest case fatality rates of any human virus, 88%
DISASTER A total of 2,615 Ebola infections and 1,427 deaths highest case fatality rates of any human virus, 88% ETYMOLOGY First recorded outbreak at,yambuku in democratic republic of congo (EBOLA RIVER)
More informationEbola Virus Disease Q&As for Nova Scotia Health Care Workers
EBOLA VIRUS DISEASE Ebola virus disease is a severe disease that causes hemorrhagic fever in humans and animals. While the likelihood of a case presenting in Nova Scotia is very low, the province s health
More informationSpecial Session on IHR and Ebola Virus Disease
Special Session on IHR and Ebola Virus Disease Roberta Andraghetti, WHO/PAHO/CHA/IR 12th Meeting Caribbean National Epidemiologists & Laboratory Directors Port of Spain, Trinidad and Tobago, 17-19 September
More informationGot Ebola? Kara Teresi, Alexandra Riedle,Anne Begley, and Victoria Torres
Got Ebola? Kara Teresi, Alexandra Riedle,Anne Begley, and Victoria Torres Ebola is being considered a Biosafety Level 4 Agent and is categorized as Category A Bioterrorism weapon in biological warfare
More informationLassa fever A neglected disease in Africa Who are the patients and what are their outcomes?
Lassa fever A neglected disease in Africa Who are the patients and what are their outcomes? A Dahmane, R Zachariah, R Van den Bergh, T Reid, Y Nzomukunda, M Allaouna,P Alders,M Van Herp,R Souya, Dr Grant,
More informationEbola Virus Disease: Pathophysiology and Clinical Aspects
Cronicon OPEN ACCESS MICROBIOLOGY Mini Review Ebola Virus Disease: Pathophysiology and Clinical Aspects Attapon Cheepsattayakorn 1,2 and Ruangrong Cheepsattayakorn 3 1 10 th Zonal Tuberculosis and Chest
More informationDoes this patient have Ebola virus disease?
Does this patient have Ebola virus disease? Pierre Tattevin, Emanuele Durante-Mangoni, Moses Massaquoi To cite this version: Pierre Tattevin, Emanuele Durante-Mangoni, Moses Massaquoi. Does this patient
More informationWHO Blood Regulators Network (BRN)
Distribution: General English only WHO Blood Regulators Network (BRN) Position Paper on Use of Convalescent Plasma, Serum or Immune Globulin Concentrates as an Element in Response to an Emerging Virus*
More informationEbola Virus Disease Update Pre-Council. October 21, 2014 Juan Ortiz, EMC Vinny Taneja, TCPH Director
Ebola Virus Disease Update Pre-Council October 21, 2014 Juan Ortiz, EMC Vinny Taneja, TCPH Director What is Ebola? Ebola is a viral disease, previously known as Ebola Hemorrhagic fever First found in 1976
More informationHeparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Temporal Aspects.
Heparin Induced Eric Kraut, MD Professor of Internal Medicine The Ohio State University Medical Center Heparin Induced Heparin induced thrombocytopenia occurs in up to 5 % of patients receiving unfractionated
More informationEbola outbreak in West Africa : Shift in paradigm
Ebola outbreak in West Africa : Shift in paradigm Dr S.C Briand, Director Pandemic and Epidemic Diseases department, WHO Geneva EVD West Africa: many "first time" Enormous epidemic in the affected countries
More informationRole of DIAGNOSTICS in BIOPREPAREDNESS Mark Miller, MD Chief Medical Officer biomerieux
Role of DIAGNOSTICS in BIOPREPAREDNESS Mark Miller, MD Chief Medical Officer biomerieux 29.09.2016 IMI Stakeholder Forum 2016 Brussels, Belgium A distant history lesson Those who cannot remember the past
More informationEbola Virus disease in West Africa : challenges and lessons learned
Ebola Virus disease in West Africa : challenges and lessons learned Pr N. Shindo Dr S.C. Briand Pandemic and Epidemic Diseases Department WHO Geneva EVD outbreak in West Africa in Numbers From24 March
More informationEBOLA IN DEMOCRATIC REPUBLIC OF CONGO (DRC) CRISIS INFO #2 06/06/2018
EBOLA IN DEMOCRATIC REPUBLIC OF CONGO (DRC) CRISIS INFO #2 06/06/2018 1. Global overview 1.1. Context So far, the outbreak (officially declared on 8 th of May) has affected the Bikoro (Bikoro and Ikoko
More informationPage 1 of 6 Interim Guidance for Emergency Medical Services (EMS) Systems and 9-1-1 Public Safety Answering Points (PSAPs) for Management of Patients Who Present With Possible Ebola Virus Disease in the
More informationObjectives. At the end of the presentation we will be able to:
Objectives At the end of the presentation we will be able to: Describe the primary functions and the nature of care in an Ebola Treatment Unit (ETU) in Liberia, Adapt lessons from West Africa to preparations
More informationTown Hall: Ebola Virus
Town Hall: Ebola Virus An outbreak of Ebola virus disease (EVD) has affected people in four countries in Western Africa (Guinea, Liberia, Sierra Leone and Nigeria) since its first detection in March of
More informationMarburg and Ebola viruses. Stephan Becker Philipps-Universität Marburg
Marburg and Ebola viruses Stephan Becker Philipps-Universität Marburg Filoviridae (order Mononegavirales) Matrix (VP40) Surface glycoprotein (GP) Lipid envelope Ribonucleoprotein complex (vrna, NP, VP35,
More informationA model to predict the propagation of Ebola. Tong Zheng Jiang
5th International Conference on Education, Management, Information and Medicine (EMIM 015) A model to redict the roagation of Ebola Tong Zheng Jiang North China Electric Power University 689, Huadian Road,
More informationFailure to Collide Ebola and Modern Medicine, 2014
Failure to Collide Ebola and Modern Medicine, 2014 Paul Farmer, MD, PhD Harvard Medical School Brigham and Women s Hospital Partners In Health Kapuscinski Development Lecture King s College London April
More information9/2/2015. Nee-Kofi Mould-Millman, MD FACEP. No conflicts of interest No financial disclosures
No conflicts of interest No financial disclosures Nee-Kofi Mould-Millman, MD FACEP Assistant Professor Dept of Emergency Medicine Senior Investigator Center for Global Health University of Colorado, School
More informationDaniel J. Mollura, MD Tara N. Palmore, MD Les R. Folio, DO David A. Bluemke, MD, PhD. Original Research n Special Report
Note: This copy is for your personal non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, contact us at www.rsna.org/rsnarights. Original Research
More informationClinical validation trial of a diagnostic for Ebola Zaire antigen detection: Design rationale and challenges to implementation
Design Clinical validation trial of a diagnostic for Ebola Zaire antigen detection: Design rationale and challenges to implementation CLINICAL TRIALS Clinical Trials 2016, Vol. 13(1) 66 72 Ó The Author(s)
More informationEmerging Infectious Diseases: Update of Ebola Virus Disease
Emerging Infectious Diseases: Update of Ebola Virus Disease Assist Prof. Nasikarn Angkasekwinai, MD., MTM&H. Division of Infectious Diseases and Tropical Medicine Department of Medicine, Faculty of Medicine
More informationProgress of vaccine and drug development for Ebola preparedness
Review article CLINICAL EXPERIMENTAL VACCINE RESEARCH Progress of vaccine and drug development for Ebola preparedness Clin Exp Vaccine Res 2015;4:11-16 http://dx.doi.org/10.7774/cevr.2015.4.1.11 pissn
More informationDerivation and Internal Validation of the Ebola Prediction Score for Risk Stratification of Patients With Suspected Ebola Virus Disease
INFECTIOUS DISEASE/ORIGINAL RESEARCH Derivation and Internal Validation of the Ebola Prediction Score for Risk Stratification of Patients With Suspected Ebola Virus Disease Adam C. Levine, MD, MPH*; Pranav
More informationBackgrounders. Ebola Virus. Author: Danielle Renwick, Copy Editor October 24, Introduction
1 of 5 31.10.2014 15:27 Backgrounders Ebola Virus Author: Danielle Renwick, Copy Editor October 24, 2014 Introduction The Ebola virus disease, formerly called the Ebola hemorrhagic fever, was first identified
More informationFrom research to large-scale use
Accelerating access to Ebola vaccines From research to large-scale use Dr Marie-Paule Kieny Assistant Director General HIS 1 Number of cases Ebola response roadmap: Situation report 3 December 2014 Sierra
More informationDiagnostics: Learning from successful experiences which made it to market. Mark Miller, MD Chief Medical Officer biomérieux France
Diagnostics: Learning from successful experiences which made it to market Mark Miller, MD Chief Medical Officer biomérieux France Diagnostics: Learning from unsuccessful experiences which almost made it
More informationFOR HEALTH WORKERS. This course can be offered as a stand-alone course or in conjunction with Ebola courses in other
EBOLA IVR mlearning COURSE FOR HEALTH WORKERS The current Ebola epidemic in West Africa is the first in the region and therefore most health workers have received no formal education on Ebola prevention,
More informationSTN: BL /5234 HSTCL PAS April 14, 2009
Rx Only MEDICATION GUIDE REMICADE (Rem-eh-kaid) (infliximab) Read the Medication Guide that comes with REMICADE before you receive the first treatment, and before each time you get a treatment of REMICADE.
More informationThe Sensitivity Comparison of Immunodiagnostic Assays for Diagnosing Dengue Fever
ORIGINAL ARTICLE Korean J Clin Lab Sci. 2016;48(4):275-279 https://doi.org/10.15324/kjcls.2016.48.4.275 pissn 1738-3544 eissn 2288-1662 Korean J Clin Lab Sci. Vol. 48, No. 4, December 2016 275 The Sensitivity
More informationDevelopment of plasma therapies for emerging infectious diseases. Dr Glenn Smith Biological Science Section Scientific Evaluation Branch
Development of plasma therapies for emerging infectious diseases Dr Glenn Smith Biological Science Section Scientific Evaluation Branch June 2017 Therapeutic Goods Administration (TGA) A part of the Australian
More informationSCHOOL OF PUBLIC HEALTH COLLEGE OF HEALTH SCIENCES UNIVERSITY OF GHANA KNOWLEDGE, ATTITUDES AND PERCEPTIONS OF COMMUNITY
SCHOOL OF PUBLIC HEALTH COLLEGE OF HEALTH SCIENCES UNIVERSITY OF GHANA KNOWLEDGE, ATTITUDES AND PERCEPTIONS OF COMMUNITY MEMBERS TOWARD THE EBOLA VIRUS DISEASE (EVD) IN PAGA, KASENA-NANKANA WEST DISTRICT
More informationPrognostic Indicators for Ebola Patient Survival
Prognostic Indicators for Ebola Patient Survival Samuel J. Crowe, 1 Matthew J. Maenner, 1 Solomon Kuah, Bobbie Rae Erickson, Megan Coffee, Barbara Knust, John Klena, Joyce Foday, Darren Hertz, Veerle Hermans,
More informationEBOLA AND PREPAREDNESS AT DENVER HEALTH. Amber Miller, MSN, RN, CIC, CSPDT, Infection Prevention Manager Denver Health
EBOLA AND PREPAREDNESS AT DENVER HEALTH Amber Miller, MSN, RN, CIC, CSPDT, Infection Prevention Manager Denver Health Denver Health and Hospital September 18, 2015 Agenda Background on Ebola Overview of
More informationAMGEN SUBMITS APPLICATIONS IN THE US AND EUROPE FOR KYPROLIS (CARFILZOMIB) FOR THE TREATMENT OF RELAPSED MULTIPLE MYELOMA
January 29, 2015 ONO PHARMACEUTICAL CO., LTD. Corporate Communications public_relations@ono.co.jp AMGEN SUBMITS APPLICATIONS IN THE US AND EUROPE FOR KYPROLIS Amgen (NASDAQ:AMGN) and its subsidiary Onyx
More informationSUNY Interim Guidance on Ebola Cleaning and Disinfection for Non-Healthcare and Non-Laboratory Settings
EBOLA VIRUS ENVIRONMENTAL CLEANING AND DISINFECTION FOR NON-HEALTHCARE AND NON-LABORATORY SETTINGS REFERENCES: NYSDOH Guidance for Local Health Departments on Ebola Virus Environmental Cleaning and Disinfection
More informationA surveillance of Ebola outbreak at Télimélé, Guinea Conakry 2014
A surveillance of Ebola outbreak at Télimélé, Guinea Conakry 2014 Jean Marie Vianney Namahoro Postgraduate student Stellenbosch University Fakulteit Geneeskunde en Gesondheidswetenskappe Faculty of Medicine
More informationEvaluation of Polymerase Chain Reaction in Early Diagnosis of Leptospirosis
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 01 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.701.294
More informationEbola by the Numbers: Not a Small-scale Killer Anymore
Ebola by the Numbers: Not a Small-scale Killer Anymore Ebola in West Africa Previously confined to Central African countries Emerged in Guinea at end of 2013 Source: Feldmann & Geisbert, Lancet 2011 Two
More informationEbola Virus Disease. BMH Medical Journal 2015;2(1):9-13 Review Article
BMH Medical Journal 2015;2(1):9-13 Review Article Ebola Virus Disease PV Bhargavan, MD, FRCP, FIMSA 1, PV Shiji, MD 2, Jare Jagannath Udhavrao 3, Nagaraj Desai 3 1 Baby Memorial Hospital, Kozhikode, Kerala,
More informationChicago Ebola Preparedness Update. Suzet McKinney, DrPH, MPH, Deputy Commissioner Stephanie Black, MD, MSc, Medical Director March 18, 2015
Chicago Ebola Preparedness Update Suzet McKinney, DrPH, MPH, Deputy Commissioner Stephanie Black, MD, MSc, Medical Director March 18, 2015 Agenda Ebola Overview Crisis in West Africa Symptoms and transmission
More informationEbola virus disease outbreak in western Africa
Action Plan Strategic Objectives 6. Promote innovation and research on new drugs International surveillance networks and information sharing on promising research Active role in research for governments
More informationHOURS CALL 117
CALL 7 HOURS STOP.ebola STOP.ebola is designed to raise awareness and encourage communication about Ebola Virus Disease. This game will help participants talk openly about Ebola; discussing their experiences,
More informationSupportive care of the first two Ebola virus disease patients at the Monrovia Medical Unit
Clinical Infectious Diseases Advance Access published May 28, 2015 Supportive care of the first two Ebola virus disease patients at the Monrovia Medical Unit 1 Karen K. Wong, Christopher L. Perdue, Jennifer
More informationEbola therapy protects severely ill monkeys
Propojení výuky oborů Molekulární a buněčné biologie a Ochrany a tvorby životního prostředí OPVK (CZ.1.07/2.2.00/28.0032) Ebola therapy protects severely ill monkeys Nature 514, 41 43 2 October 2014 Published
More informationSYMPTOM CONTROL? PEDIATRICS
IS YOUR CHILD READY FOR SYMPTOM CONTROL? PEDIATRICS For children ages 6-17 with moderately to severely active Crohn s disease or ulcerative colitis (UC) who haven t responded well to other therapies SELECTED
More informationIGRAs for Serial Testing of Healthcare Workers
IGRAs for Serial Testing of Healthcare Workers Jason Stout, MD, MHS Wake County TB Medical Consultant NC TB Medical Director Division of Infectious Diseases, Duke University Medical Center Disclosures-Funding
More informationCase study: Nubia s mother Experimental drugs and pregnancy in the Ebola epidemic West-Africa
Case study: Nubia s mother Experimental drugs and pregnancy in the 2014-2016 Ebola epidemic West-Africa 3-4 nov 2016 Buenos Aires Argentina Séverine Caluwaerts, OBGYN, MPH 1 The setting : 2014-2016 Ebola
More informationDEVELOPMENT OF AN EBOLA VACCINE IN THE MIDST OF AN UNPRECEDENTED EPIDEMIC
DEVELOPMENT OF AN EBOLA VACCINE IN THE MIDST OF AN UNPRECEDENTED EPIDEMIC Jayanthi Wolf, Ph.D. Director, Global Regulatory Affairs Merck, Sharp & Dohme Presentation Outline Vaccine Development for Emerging
More informationControl of Ebola Virus Disease Firestone District, Liberia, 2014
Morbidity and Mortality Weekly Report / Vol. 63 October 21, 2014 Control of Ebola Virus Disease Firestone District, Liberia, 2014 Erik J. Reaves, DO 1, Lyndon G. Mabande, MD 2, Douglas A. Thoroughman,
More informationTropical Medicine & International Health
MSF Field Research Ebola outbreak in rural West Africa: epidemiology, clinical features and outcomes Authors Citation DOI Publisher Journal Rights Dallatomasinas, Silvia; Crestani, Rosa; Squire, James
More informationHEAD-TO-HEAD PHASE 3 TRIAL OF KYPROLIS (CARFILZOMIB) VERSUS VELCADE (BORTEZOMIB) MET PRIMARY ENDPOINT OF PROGRESSION-FREE SURVIVAL
ONO PHARMACEUTICAL CO.,LTD. Corporate Communications Mail:public_relations@ono.co.jp March 2, 2015 HEAD-TO-HEAD PHASE 3 TRIAL OF KYPROLIS (CARFILZOMIB) VERSUS VELCADE (BORTEZOMIB) MET PRIMARY ENDPOINT
More informationAnnouncements. Please mute your phones and DO NOT place us on hold. Press *6 to mute/unmute your phone.
1 Announcements Register for the Epi-Tech Trainings: 1. Log-on or Request log-on ID/password: https://tiny.army.mil/r/zb8a/cme 2. Register for Epi-Tech Surveillance Training: https://tiny.army.mil/r/leaid/epitechfy15
More information10/8/2013. Drug-induced immune thrombocytopenia (DITP) Clinical aspects
Richard Aster, MD Blood Center of Wisconsin, Blood Research Institute, Milwaukee, WI Senior Investigator Medical College of Wisconsin Professor, Departments of Medicine & Pathology Drug-induced immune
More informationMEDICATION GUIDE REMICADE (Rem-eh-kaid) (infliximab) What is the most important information I should know about REMICADE?
MEDICATION GUIDE REMICADE (Rem-eh-kaid) (infliximab) Read the Medication Guide that comes with REMICADE before you receive the first treatment, and before each time you get a treatment of REMICADE. This
More informationThe International Collaborative Conference in Clinical Microbiology & Infectious Diseases PLUS:
The International Collaborative Conference in Clinical Microbiology & Infectious Diseases PLUS: Antimicrobial stewardship in hospitals: Improving outcomes through better education and implementation of
More informationMEDICATION GUIDE REMICADE (Rem-eh-kaid) (infliximab)
MEDICATION GUIDE REMICADE (Rem-eh-kaid) (infliximab) Read the Medication Guide that comes with REMICADE before you receive the first treatment, and before each time you get a treatment of REMICADE. This
More informationLogistics. Registration for free continuing education (CE) hours or certificate of attendance through TRAIN at:
. DSHS Grand Rounds Logistics Registration for free continuing education (CE) hours or certificate of attendance through TRAIN at: https://tx.train.org Streamlined registration for individuals not requesting
More informationEbola Convalescent Plasma: Considerations for future outbreaks
Ebola Convalescent Plasma: Considerations for future outbreaks Based on EVD-001 and -002 Monrovia; Liberia Nov 2014-Jan 2015 For IPFA s Workshop on Improving Access to Plasma and Plasma Products in the
More information